Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar snakeflake (34.48) Submitted: 4/28/2010 8:54:13 AM : Outperform Start Price: $21.41 MYL Score: -9.93

Just got FDA approval to market generic versions of Flomax and Desoxin

Featured Broker Partners


Advertisement